Extended spectrum beta lactamase (ESBL)
Fecal microbiota transplantation against intestinal colonization by extended spectrum beta lactamase producing Enterobacteriaceae: a proof of principle study
... of extended spectrum beta lactamase (ESBL) genes in Enterobacteriaceae leads to delayed effective treatment of infections with these multire- sistant microorganisms, which is associated with ...
6
Prevalence and antimicrobial susceptibility patterns of extended spectrum beta lactamase producing Entrobacteriaceae in the University of Gondar Referral Hospital environments, northwest Ethiopia
... An extended spectrum beta-lactamase production has been observed mostly in Entrobacteriaceae, and their resistance increased mainly due to the spreading of ESBL and the emergence of different ...
7
The Frequency of Extended Spectrum Beta Lactamase (ESBL) in Escherichia coli and Klebsiella pneumoniae: A Report from Mashhad, Iran
... Background: In recent decades, extended spectrum beta-lactamase (ESBL) producing bacteria have increased worldwide. The most important causative agents of nosocomial infections throughout the ...
8
<p>Multilocus sequence typing and <em>bla</em><sub>ESBL</sub> characterization of extended-spectrum beta-lactamase-producing <em>Escherichia coli</em> isolated from healthy humans and swine in Northern Thailand</p>
... to beta-lactam antibiotics expres- sing extended-spectrum beta-lactamase (ESBL) ...The extended-spectrum beta-lactamase-producing ...
14
High incidence of antimicrobial resistant organisms including extended spectrum beta lactamase producing Enterobacteriaceae and methicillin resistant Staphylococcus aureusin nasopharyngeal and blood isolates of HIV infected children from Cape Town, South Africa
... tests. Extended spectrum beta-lactamase (ESBL) production was detected using the double disc diffusion test, by placing a disc with amoxicillin/clavulanate adja- cent to discs with cefotaxime ...
10
Extended spectrum beta-lactamase and metallo beta-lactamase production among Escherichia coli and Klebsiella pneumoniae isolated from different clinical samples in a tertiary care hospital in Kathmandu, Nepal
... Background: Extended spectrum beta-lactamase (ESBL) and metallo beta-lactamase (MBL) production in Klebsiella pneumoniae and Escherichia coli are the commonest modes of drug ...
7
Diagnostic Validity of Cica Beta Test 1 for the Detection of Extended Spectrum Beta Lactamase (ESBL) Producing Gram Negative Bacteria by Comparing with Phenotypic Method
... of extended spectrum beta lactamase producing bacteria is an important issue in the clinical ...Cica Beta Test 1 for detection of extended spectrum ...
10
Ertapenem susceptibility of extended spectrum beta-lactamase-producing organisms
... Background: Infections caused by multiply drug resistant organisms such as extended spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae are increasing. ...
5
Molecular detection and antibiotic resistance pattern of extended-spectrum beta-lactamase producing Escherichia coli in a Tertiary Hospital in Enugu, Nigeria
... organisms. Extended-spectrum beta-lactamases are enzymes hydrolyzing the beta lactam antibiotics, including third generation cephalosporins and monobactams but not cephamycins and carbapen- ...
7
Clinical profiles of patients colonized or infected with extended spectrum beta lactamase producing Enterobacteriaceae isolates: a 20 month retrospective study at a Belgian University Hospital
... Clinical profiles of patients colonized or infected with extended-spectrum beta-lactamase producing Enterobacteriaceae isolates: a 20 month retrospective study at a Belgian University Ho[r] ...
10
Changing epidemiology of infections due to extended spectrum beta-lactamase producing bacteria
... 23. Johnson JR, Urban C, Weissman SJ, Jorgensen JH, Lewis JS 2nd, Hansen G, Edelstein PH, Robicsek A, Cleary T, Adachi J, Paterson D, Quinn J, Hanson ND, Johnston BD, Clabots C, Kuskowski MA, AMERECUS Investigators: ...
6
A comparative study of ciprofloxacin resistance in extended spectrum beta-lactamase and non- extended spectrum beta-lactamase producing enterobacteriaceae in a tertiary care hospital
... infections. Beta- lactams and fluoroquinolone antimicrobial agents are most commonly used as treatment of these bacterial ...infections. Extended- spectrum beta-lactamases (ESBLs) produced by ...
9
Prevalance of extended spectrum beta lactamase producing uropathogenic eschereria coli and antimicrobial susceptibility pattern in a tertiarycare hospital in North India
... Urinary tract infections (UTIs) remain the common infections in outpatients as well as Lactamase producing organisms causing urinary tract UTI) are increasing in incidence and pose a major burden to health care. ...
5
Clinical outcome of empiric antimicrobial therapy of bacteremia due to extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae
... Findings: A retrospective surveillance study of all patients with bacteremias caused by ESBL-producing E. coli and K. pneumoniae (EK-ESBL) from 2000-2007 in the Calgary Health Region was conducted. Data were available ...
7
Evaluation of The Effect of Antimicrobial Activity of Ethanol Extract of Calotropis Procera in Extended Spectrum Beta- Lactamase Producing E. Coli
... Infectious diseases are responsible for thousands of worldwide early death .Many commercial antibiotics have been used to control human's infectious diseases all over the world. Calotropis procera Linn a wild growing ...
5
Prevalence of extended-spectrum beta-lactamase-producing bacteria in food
... Abstract: Extended-spectrum b-lactamase (ESBL)-producing Enterobacteriaceae with Cefotaximase–München (CTX-M) enzymes are rapidly increasing worldwide and pose a threat to health ...
5
A study on Prevalence of extended spectrum Beta lactamase and Amp C Beta lactamase production among escherichia coli and Klebsiella isolated in Urinary Tract Infection.
... the present study, no resistance was noticed to Imipenam. Imipenam should be used as the second line of drug to prevent further resistance and rest of the drugs can be used as the first line of choice. The routine ...
104
Randomized controlled trial of piperacillin tazobactam, cefepime and ertapenem for the treatment of urinary tract infection caused by extended spectrum beta lactamase producing Escherichia coli
... Currently, the most frequently mentioned alternative treatments are beta-lactam/beta-lactamase inhibitors (BLBLI), cephamycins, cefepime, and aminoglycosides [10 – 20]. Results have been promising, ...
9
Piperacillin–tazobactam as alternative to carbapenems for ICU patients
... particulary beta‑lactam/beta‑lactamase inhibitor combinations, can be used for therapy of extended‑spectrum beta‑lactamase‑producing Enterobacteriaceae (ESBL‑ PE)‑related ...
17
Imported PER-1 producing Pseudomonas aeruginosa, PER-1 producing Acinetobacter baumanii and VIM-2-producing Pseudomonas aeruginosa strains in Hungary
... acquired beta-lactamases encoded by mobile genetic elements are important resistance mechanism in ...to beta- lactams can lead to therapeutic failure, especially when it is associated with resistance to ...
5